{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:52:16Z","timestamp":1776423136022,"version":"3.51.2"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"10","funder":[{"DOI":"10.13039\/100000072","name":"NIDCR","doi-asserted-by":"crossref","award":["R35DE026631"],"award-info":[{"award-number":["R35DE026631"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Performance of commercially available human papillomavirus (HPV) assays (approved for cervical HPV detection) is unknown for detecting HPV-related oropharyngeal cancer (HPV-OPC). Assays for detection of HPV DNA [ELISA (DEIA) and Cobas], and RNA (Aptima) in oral rinse samples, and serum HPV oncogene antibodies were evaluated. Sensitivity and specificity of each test was explored among HPV-OPC cases and controls. Biomarker prevalence was evaluated among 294 \u201cat-risk\u201d people (screening) and 133 \u201chigh-risk\u201d people [known to previously have oral oncogenic HPV (oncHPV) DNA and\/or HPV16 E6\/E7 antibodies detected]. HPV16 E6 antibodies had the best overall test performance with sensitivity of 88%, compared with oral HPV16 DNA sensitivity of 51% by DEIA and 43% by Cobas (each P &amp;lt; 0.001). Specificity was comparable in each of these tests (\u226598%). When positivity for any oncHPV type was compared with HPV16 for the same test, sensitivity was comparable (60% vs. 51%, 40% vs. 43%, and 92% vs. 88% for DEIA, Cobas, and E6 antibodies, respectively), but specificity was reduced (93%\u201397%). Aptima had poor sensitivity (23%). Sensitivity decreased when cotesting HPV16 oral rinse DNA and E6 antibodies (37%\u201348%), or multiple E antibodies (69%\u201372%). HPV16 DNA were detected in \u223c2% of the at-risk by either DEIA or Cobas and up to 15% of the high-risk population. HPV16 E6 seroprevalence was 2.3% and 2.4% in the at-risk and high-risk populations, respectively. Oral rinse HPV testing had moderate-to-poor sensitivity for HPV-OPC, suggesting many true positives would be missed in a potential screening scenario. HPV16 E6 serum antibody was the most promising biomarker evaluated.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-19-0185","type":"journal-article","created":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T17:15:31Z","timestamp":1565975731000},"page":"689-700","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer"],"prefix":"10.1158","volume":"12","author":[{"given":"Gypsyamber","family":"D'Souza","sequence":"first","affiliation":[{"name":"1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland."},{"name":"2Department of Otolaryngology - Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwendolyn","family":"Clemens","sequence":"additional","affiliation":[{"name":"3Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Troy","sequence":"additional","affiliation":[{"name":"1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel G.","family":"Castillo","sequence":"additional","affiliation":[{"name":"1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Struijk","sequence":"additional","affiliation":[{"name":"4DDL Diagnostic Laboratory, Rijswijk, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Waterboer","sequence":"additional","affiliation":[{"name":"5Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2542-9949","authenticated-orcid":false,"given":"Noemi","family":"Bender","sequence":"additional","affiliation":[{"name":"5Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip M.","family":"Pierorazio","sequence":"additional","affiliation":[{"name":"6Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon R.","family":"Best","sequence":"additional","affiliation":[{"name":"2Department of Otolaryngology - Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Strickler","sequence":"additional","affiliation":[{"name":"7Department of Epidemiology & Public Health, Albert Einstein College of Medicine, Bronx, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9416-473X","authenticated-orcid":false,"given":"Dorothy J.","family":"Wiley","sequence":"additional","affiliation":[{"name":"8University of California, Los Angeles School of Nursing, Los Angeles, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert I.","family":"Haddad","sequence":"additional","affiliation":[{"name":"9Division of Head and Neck Oncology, Dana Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall","family":"Posner","sequence":"additional","affiliation":[{"name":"10Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole","family":"Fakhry","sequence":"additional","affiliation":[{"name":"1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland."},{"name":"6Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"key":"2022060815374032000_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.oraloncology.2017.09.015","article-title":"40-year incidence trends for oropharyngeal squamous cell carcinoma in the United States","volume":"74","author":"Osazuwa-Peters","year":"2017","journal-title":"Oral Oncol"},{"key":"2022060815374032000_bib2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.oraloncology.2017.02.019","article-title":"Rising incidence of oral tongue cancer among white men and women in the United States, 1973\u20132012","volume":"67","author":"Tota","year":"2017","journal-title":"Oral Oncol"},{"key":"2022060815374032000_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejca.2017.05.026","article-title":"Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: a systematic review","volume":"82","author":"Hussein","year":"2017","journal-title":"Eur J Cancer"},{"key":"2022060815374032000_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/jamaoncol.2015.5504","article-title":"Associations of oral \u03b1-, \u03b2-, and \u03b3-human papillomavirus types with risk of incident head and neck cancer","volume":"2","author":"Agalliu","year":"2016","journal-title":"JAMA Oncol"},{"key":"2022060815374032000_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canep.2016.06.002","article-title":"Human Papillomavirus (HPV) 16 E6 seropositivity is elevated in subjects with oral HPV16 infection","volume":"43","author":"Zhang","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"2022060815374032000_bib6","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1200\/JCO.2012.47.2738","article-title":"Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer","volume":"31","author":"Kreimer","year":"2013","journal-title":"J Clin Oncol"},{"key":"2022060815374032000_bib7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.oraloncology.2017.08.014","article-title":"Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer","volume":"73","author":"Anderson","year":"2017","journal-title":"Oral Oncol"},{"key":"2022060815374032000_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jnci\/djq001","article-title":"Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection","volume":"102","author":"Rodr\u00edguez","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"2022060815374032000_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/aje\/kwn036","article-title":"Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis","volume":"168","author":"Koshiol","year":"2008","journal-title":"Am J Epidemiol"},{"key":"2022060815374032000_bib10","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement","volume":"320","author":"US Preventive Services Task Force","year":"2018","journal-title":"JAMA"},{"key":"2022060815374032000_bib11","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/annonc\/mdx535","article-title":"Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer","volume":"28","author":"D'Souza","year":"2017","journal-title":"Ann Oncol"},{"key":"2022060815374032000_bib12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1158\/1940-6207.CAPR-14-0296","article-title":"Long-term persistence of oral human papillomavirus type 16: the HPV Infection in Men (HIM) study","volume":"8","author":"Pierce Campbell","year":"2015","journal-title":"Cancer Prev Res"},{"key":"2022060815374032000_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/aje\/kwu247","article-title":"Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults","volume":"181","author":"Beachler","year":"2015","journal-title":"Am J Epidemiol"},{"key":"2022060815374032000_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.oraloncology.2018.04.005","article-title":"The epidemiology of oral human papillomavirus infection in healthy populations: a systematic review and meta-analysis","volume":"82","author":"Tam","year":"2018","journal-title":"Oral Oncol"},{"key":"2022060815374032000_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.oraloncology.2017.12.008","article-title":"Sensitivity and specificity of oral HPV detection for HPV-positive head and neck cancer","volume":"77","author":"Gipson","year":"2018","journal-title":"Oral Oncol"},{"key":"2022060815374032000_bib16","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1002\/ijc.30697","article-title":"Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma","volume":"140","author":"Holzinger","year":"2017","journal-title":"Int J Cancer"},{"key":"2022060815374032000_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.oraloncology.2018.05.015","article-title":"Biomarkers for early identification of recurrences in HPV-driven oropharyngeal cancer","volume":"82","author":"Mirghani","year":"2018","journal-title":"Oral Oncol"},{"key":"2022060815374032000_bib18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/jamaoncol.2015.2524","article-title":"Prognostic implication of persistent human papillomavirus type 16 DNA detection in oral rinses for human papillomavirus-related oropharyngeal carcinoma","volume":"1","author":"Rettig","year":"2015","journal-title":"JAMA Oncol"},{"key":"2022060815374032000_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1158\/1940-6207.CAPR-15-0299","article-title":"Serum antibodies to HPV16 early proteins warrant investigation as potential biomarkers for risk stratification and recurrence of HPV-associated oropharyngeal cancer","volume":"9","author":"Fakhry","year":"2016","journal-title":"Cancer Prev Res"},{"key":"2022060815374032000_bib20","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1158\/1078-0432.CCR-16-1617","article-title":"E6 and E7 antibody levels are potential biomarkers of recurrence in patients with advanced-stage human papillomavirus-positive oropharyngeal squamous cell carcinoma","volume":"23","author":"Spector","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2022060815374032000_bib21","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/jamaoto.2014.1338","article-title":"Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer","volume":"140","author":"Ahn","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2022060815374032000_bib22","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1200\/JCO.2014.55.1341","article-title":"Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners","volume":"32","author":"D'Souza","year":"2014","journal-title":"J Clin Oncol"},{"key":"2022060815374032000_bib23","article-title":"Men and women offering understanding of throat HPV (MOUTH Study) [Internet]","author":"NIDCR"},{"key":"2022060815374032000_bib24","article-title":"MACS\/WIHS Combined Cohort Study [Internet]"},{"key":"2022060815374032000_bib25","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/infdis\/jiv273","article-title":"High oral human papillomavirus type 16 load predicts long-term persistence in individuals with or at risk for HIV infection","volume":"212","author":"Beachler","year":"2015","journal-title":"J Infect Dis"},{"key":"2022060815374032000_bib26","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/JCM.37.8.2508-2517.1999","article-title":"Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus","volume":"37","author":"Kleter","year":"1999","journal-title":"J Clin Microbiol"},{"key":"2022060815374032000_bib27","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0002-9440(10)65688-X","article-title":"Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses","volume":"153","author":"Kleter","year":"1998","journal-title":"Am J Pathol"},{"key":"2022060815374032000_bib28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.4424","article-title":"Are 20 human papillomavirus types causing cervical cancer?","volume":"234","author":"Arbyn","year":"2014","journal-title":"J Pathol"},{"key":"2022060815374032000_bib29","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1373\/clinchem.2005.052381","article-title":"Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins","volume":"51","author":"Waterboer","year":"2005","journal-title":"Clin Chem"},{"key":"2022060815374032000_bib30","first-page":"34","article-title":"What makes a screening exam \u201cgood\u201d?","volume":"8","author":"Herman","year":"2006","journal-title":"Virtual Mentor VM"},{"key":"2022060815374032000_bib31","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol"},{"key":"2022060815374032000_bib32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/LGT.0000000000000393","article-title":"Aptima human papillomavirus E6\/E7 mRNA test results strongly associated with risk for high-grade cervical lesions in follow-up biopsies","volume":"22","author":"Ge","year":"2018","journal-title":"J Low Genit Tract Dis"},{"key":"2022060815374032000_bib33","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/cncy.21875","article-title":"Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer","volume":"125","author":"Ge","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"2022060815374032000_bib34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/ijc.31819","article-title":"HPV-mRNA and HPV-DNA detection in samples taken up to seven years before severe dysplasia of cervix uteri","volume":"144","author":"Forslund","year":"2019","journal-title":"Int J Cancer"},{"key":"2022060815374032000_bib35","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jamaoto.2019.0119","article-title":"Human papillomavirus genotype detection in oral gargle samples among men with newly diagnosed oropharyngeal squamous cell carcinoma","volume":"145","author":"Martin-Gomez","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2022060815374032000_bib36","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1002\/cncr.30966","article-title":"Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence","volume":"123","author":"Lang Kuhs","year":"2017","journal-title":"Cancer"},{"key":"2022060815374032000_bib37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.canep.2016.03.003","article-title":"Characterization of human papillomavirus antibodies in individuals with head and neck cancer","volume":"42","author":"Lang Kuhs","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"2022060815374032000_bib38","doi-asserted-by":"crossref","first-page":"109393","DOI":"10.18632\/oncotarget.22682","article-title":"Detection of HPV related oropharyngeal cancer in oral rinse specimens","volume":"8","author":"Rosenthal","year":"2017","journal-title":"Oncotarget"},{"key":"2022060815374032000_bib39","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/00016489.2016.1274426","article-title":"Usefulness of human papillomavirus detection in oral rinse as a biomarker of oropharyngeal cancer","volume":"137","author":"Yoshida","year":"2017","journal-title":"Acta Otolaryngol (Stockh)"},{"key":"2022060815374032000_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx005","article-title":"Kinetics of the human papillomavirus type 16 E6 antibody response prior to oropharyngeal cancer","volume":"109","author":"Kreimer","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"2022060815374032000_bib41","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1002\/cncr.30955","article-title":"Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer","volume":"123","author":"Dahlstrom","year":"2017","journal-title":"Cancer"},{"key":"2022060815374032000_bib42","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma","volume":"33","author":"Gillison","year":"2015","journal-title":"J Clin Oncol"},{"key":"2022060815374032000_bib43","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"2022060815374032000_bib44","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1200\/JCO.2014.57.8435","article-title":"Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study","volume":"33","author":"Kreimer","year":"2015","journal-title":"J Clin Oncol"},{"key":"2022060815374032000_bib45","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/LGT.0000000000000458","article-title":"International Anal Neoplasia Society Guidelines for the Practice of Digital Anal Rectal Examination","volume":"23","author":"Hillman","year":"2019","journal-title":"J Low Genit Tract Dis"},{"key":"2022060815374032000_bib46","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/0956462415615764","article-title":"Anal dysplasia in HIV-infected women: a commentary on the field","volume":"28","author":"Godfrey","year":"2017","journal-title":"Int J STD AIDS"},{"key":"2022060815374032000_bib47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/apc.2017.0063","article-title":"Review: anal intraepithelial neoplasia in HIV-infected men who have sex with men: is screening and treatment justified?","volume":"31","author":"Wasserman","year":"2017","journal-title":"AIDS Patient Care STDs"},{"key":"2022060815374032000_bib48","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1128\/JCM.03517-13","article-title":"Analytic and clinical performance of cobas HPV testing in anal specimens from HIV-positive men who have sex with men","volume":"52","author":"Wentzensen","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2022060815374032000_bib49","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/QAD.0000000000001462","article-title":"The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men","volume":"31","author":"Jin","year":"2017","journal-title":"AIDS"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/12\/10\/689\/2335753\/689.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/12\/10\/689\/2335753\/689.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T11:54:09Z","timestamp":1654689249000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/12\/10\/689\/47186\/Evaluating-the-Utility-and-Prevalence-of-HPV"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,1]]},"published-print":{"date-parts":[[2019,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-19-0185","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.c.6547075","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22533415","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22533415.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6547075.v1","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]}}}